These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 36372301)

  • 1. Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor.
    Liu HJ; Xu P
    Adv Drug Deliv Rev; 2022 Dec; 191():114619. PubMed ID: 36372301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
    Ju X; Miao T; Chen H; Ni J; Han L
    Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Brain Barrier- and Blood-Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases.
    Chen L; Zeng D; Xu N; Li C; Zhang W; Zhu X; Gao Y; Chen PR; Lin J
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41889-41897. PubMed ID: 31615203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.
    Hersh AM; Alomari S; Tyler BM
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
    Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J
    ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patented nanomedicines for the treatment of brain tumors.
    Caruso G; Raudino G; Caffo M
    Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-assisted brain delivery of nanomedicines for brain tumor therapy: advance and prospect.
    Zhang S; Zhang S; Luo S; Tang P; Wan M; Wu D; Gao W
    J Nanobiotechnology; 2022 Jun; 20(1):287. PubMed ID: 35710426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcellular brain drug delivery: A review on recent advancements.
    Azarmi M; Maleki H; Nikkam N; Malekinejad H
    Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.
    Zhou Q; Dong C; Fan W; Jiang H; Xiang J; Qiu N; Piao Y; Xie T; Luo Y; Li Z; Liu F; Shen Y
    Biomaterials; 2020 May; 240():119902. PubMed ID: 32105817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcytosis-enabled active extravasation of tumor nanomedicine.
    Zhou Q; Li J; Xiang J; Shao S; Zhou Z; Tang J; Shen Y
    Adv Drug Deliv Rev; 2022 Oct; 189():114480. PubMed ID: 35952830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for brain cancer.
    Quader S; Kataoka K; Cabral H
    Adv Drug Deliv Rev; 2022 Mar; 182():114115. PubMed ID: 35077821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized Nanomaterials Capable of Crossing the Blood-Brain Barrier.
    Zha S; Liu H; Li H; Li H; Wong KL; All AH
    ACS Nano; 2024 Jan; 18(3):1820-1845. PubMed ID: 38193927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.
    Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H
    J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.
    Ferraris C; Cavalli R; Panciani PP; Battaglia L
    Int J Nanomedicine; 2020; 15():2999-3022. PubMed ID: 32431498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma.
    Qiao L; Yang H; Shao XX; Yin Q; Fu XJ; Wei Q
    Mol Pharm; 2022 Jul; 19(7):1927-1951. PubMed ID: 35499303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.